This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Lissy F. Jarvik, MD, PhD; Nutan P. Bishun, PhD; Herman Bleiweiss, MD; Takashi Kato, MD; Emilia Moralishvili, MS

Arch Gen Psychiatry. 1971;24(2):166-168.

Abstract
Because of a report in the literature that three patients on lithium carbonate showed chromosome damage in excess of that seen in controls, peripheral blood cultures were set up from 16 manic-depressive patients who had taken lithium carbonate for periods of two weeks to over two years (seven of them for one year or more), from four manic-depressive patients on placebo, and from ten control subjects. Even though the highest average frequency of breaks occurred in the lithium carbonate group (3.3%), the value corresponded to the means (1.9% to 4.3%) generally observed in our laboratory and the difference between the lithium carbonate group and the present controls (1.5% breaks) did not reach statistical significance.

Author Affiliations
New York

From the Department of Medical Genetics, New York State Psychiatric Institute and the Department of Psychiatry, College of Physicians and Surgeons, Columbia University, New York. Dr. Bishun is now at the Marie Curie Memorial Foundation, Surry, England. Dr. Bleiweiss is now at the Instituto de Genetica Medica, Buenos Aires. Dr. Kato is now at the Otaru Seiwa Hospital, Otaru, Hokkaido, Japan.

Footnotes
Accepted for publication April 24, 1970.

Reprint requests to Department of Medical Genetics, New York State Psychiatric Institute, 722 W 168th St, New York 10032 (Dr. Jarvik).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?